Poonaki, E.; Nickel, A.-C.; Shafiee Ardestani, M.; Rademacher, L.; Kaul, M.; Apartsin, E.; Meuth, S.G.; Gorji, A.; Janiak, C.; Kahlert, U.D.
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. Int. J. Mol. Sci. 2022, 23, 5479.
https://doi.org/10.3390/ijms23105479
AMA Style
Poonaki E, Nickel A-C, Shafiee Ardestani M, Rademacher L, Kaul M, Apartsin E, Meuth SG, Gorji A, Janiak C, Kahlert UD.
CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. International Journal of Molecular Sciences. 2022; 23(10):5479.
https://doi.org/10.3390/ijms23105479
Chicago/Turabian Style
Poonaki, Elham, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak, and Ulf Dietrich Kahlert.
2022. "CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells" International Journal of Molecular Sciences 23, no. 10: 5479.
https://doi.org/10.3390/ijms23105479
APA Style
Poonaki, E., Nickel, A. -C., Shafiee Ardestani, M., Rademacher, L., Kaul, M., Apartsin, E., Meuth, S. G., Gorji, A., Janiak, C., & Kahlert, U. D.
(2022). CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells. International Journal of Molecular Sciences, 23(10), 5479.
https://doi.org/10.3390/ijms23105479
